サンプル依頼リスト カート
  • English
  • Korean
表紙：急性呼吸窮迫症候群（ARDS）治療の世界市場規模調査＆予測：薬剤クラス別、投与経路別、流通チャネル別、地域別分析、2023-2030年
市場調査レポート
商品コード
1303557

急性呼吸窮迫症候群（ARDS）治療の世界市場規模調査＆予測：薬剤クラス別、投与経路別、流通チャネル別、地域別分析、2023-2030年

Global Acute Respiratory Distress Syndrome Treatment Market Size study & Forecast, by Drug Class, By Route of Administration, By Distribution Channel and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
急性呼吸窮迫症候群（ARDS）治療の世界市場規模調査＆予測：薬剤クラス別、投与経路別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

急性呼吸窮迫症候群（ARDS）は、肺炎、敗血症、外傷、吸入損傷など、さまざまな基礎的原因に反応して起こりうる病状です。

ARDSは肺の炎症と体液の蓄積を特徴とし、重度の息切れや呼吸不全を引き起こします。急性呼吸窮迫症候群（ARDS）治療市場は、早産の増加や呼吸器疾患の有病率の増加などの要因により拡大しています。ARDSの治療には通常、呼吸を補助するための機械的人工呼吸、補助酸素、症状管理と合併症予防のための薬物療法などの支持療法が含まれます。ARDSの有病率は過去数十年の間に徐々に増加しています。

世界保健機関（WHO）によると、毎年推定1,500万人の赤ちゃんが早産で生まれています。さらに、国によって早産の割合は5％から18％です。さらに、低所得国で生まれた超早産児の90％以上が生後数日以内に死亡しているが、高所得国で死亡する超早産児は10％未満です。宇宙を推進するもう一つの重要な要素は、呼吸器疾患の有病率の増加です。世界保健機関（WHO）によると、喘息は2019年に推定2億6,200万人が罹患し、4億5,500万人が死亡しました。また、慢性閉塞性肺疾患は世界第3位の死因であり、323万人の死亡を引き起こしている70歳未満のCOPDによる死亡の90％近くは、2019年に低・中所得国で発生しています。また、診断需要の増加や医療検査機器の技術進歩の高まりは、予測期間中に市場に有利な成長見通しを生み出すと思われます。しかし、急性呼吸窮迫症候群（ARDS）治療の高コストが、2023-2030年の予測期間を通じて市場の成長を阻害します。

急性呼吸窮迫症候群（ARDS）治療の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、技術の進歩と治療プロセスを改善するための数多くの最先端の薬理学的分子の利用可能性により、2022年の市場を独占しました。Statistaによると、米国における慢性閉塞性肺疾患の有病率は、2050年までに成人の約11.6％まで増加すると予想されています。アジア太平洋地域は、市場空間におけるバイオテクノロジー研究・センター活動の増加により、予測期間中に大きく成長すると予想されています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 急性呼吸窮迫症候群（ARDS）治療市場：地域別、2020年～2030年
    • 急性呼吸窮迫症候群（ARDS）治療市場：薬剤クラス別、2020-2030年
    • 急性呼吸窮迫症候群（ARDS）治療市場：投与経路別、2020-2030年
    • 急性呼吸窮迫症候群（ARDS）治療市場：流通チャネル別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 急性呼吸窮迫症候群（ARDS）治療の世界市場定義とスコープ

  • 調査目的
  • 市場の定義と範囲
    • 産業の発展
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の急性呼吸窮迫症候群（ARDS）治療市場力学

  • 急性呼吸窮迫症候群（ARDS）治療市場の影響分析（2020-2030年）
    • 市場促進要因
      • 早産患者の増加
      • 呼吸器疾患の増加
    • 市場の課題
      • 急性呼吸窮迫症候群（ARDS）治療の高コスト
    • 市場機会
      • 診断需要の増加
      • 医療検査機器の技術進歩の高まり

第4章 世界の急性呼吸窮迫症候群（ARDS）治療市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 急性呼吸窮迫症候群（ARDS）治療の世界市場：薬剤クラス別

  • 市場スナップショット
  • 急性呼吸窮迫症候群（ARDS）治療の世界市場：薬剤クラス別、業績-潜在能力分析
  • 急性呼吸窮迫症候群（ARDS）治療の世界市場：薬剤クラス別推定・予測、2020-2030年
  • 急性呼吸窮迫症候群（ARDS）治療市場、サブセグメント別分析
    • 血管収縮薬
    • 気管支拡張薬
    • ステロイド・抗生物質
    • その他

第6章 急性呼吸窮迫症候群（ARDS）治療の世界市場：投与経路別

  • 市場スナップショット
  • 急性呼吸窮迫症候群（ARDS）治療の世界市場：投与経路別、業績-潜在能力分析
  • 急性呼吸窮迫症候群（ARDS）治療の世界市場：投与経路別推定・予測、2020-2030年
  • 急性呼吸窮迫症候群（ARDS）治療市場、サブセグメント分析
    • 経口
    • 注射
    • 吸入

第7章 急性呼吸窮迫症候群（ARDS）治療剤の世界市場：流通チャネル別

  • 市場スナップショット
  • 急性呼吸窮迫症候群（ARDS）治療の世界市場：流通チャネル別、業績-潜在能力分析
  • 急性呼吸窮迫症候群（ARDS）治療の世界市場：流通チャネル別推定・予測、2020-2030年
  • 急性呼吸窮迫症候群（ARDS）治療市場、サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他

第8章 急性呼吸窮迫症候群（ARDS）治療の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 急性呼吸窮迫症候群（ARDS）治療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 薬剤クラスの推定・予測、2020-2030年
      • 投与経路別の推定・予測、2020～2030年
      • 流通チャネル別の推定・予測、2020～2030年
    • カナダ
  • 欧州の急性呼吸窮迫症候群（ARDS）治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の急性呼吸窮迫症候群（ARDS）治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの急性呼吸窮迫症候群（ARDS）治療市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Hoffmann-La Roche Ltd
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd
    • Novartis AG
    • Dragerwerk AG & Co. KGaA
    • Fisher & Paykel Healthcare Limited
    • LivaNova PLC
    • Besmed Health Business Corp
    • Armstrong Medical
    • Pfizer Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Acute Respiratory Distress Syndrome Treatment Market, report scope
  • TABLE 2. Global Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
  • TABLE 4. Global Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 5. Global Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Acute Respiratory Distress Syndrome Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Acute Respiratory Distress Syndrome Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Acute Respiratory Distress Syndrome Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Acute Respiratory Distress Syndrome Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Acute Respiratory Distress Syndrome Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Acute Respiratory Distress Syndrome Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Acute Respiratory Distress Syndrome Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Acute Respiratory Distress Syndrome Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Acute Respiratory Distress Syndrome Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Acute Respiratory Distress Syndrome Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Acute Respiratory Distress Syndrome Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Acute Respiratory Distress Syndrome Treatment Market
  • TABLE 71. List of primary sources, used in the study of global Acute Respiratory Distress Syndrome Treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Acute Respiratory Distress Syndrome Treatment Market, research methodology
  • FIG 2. Global Acute Respiratory Distress Syndrome Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Acute Respiratory Distress Syndrome Treatment Market, key trends 2022
  • FIG 5. Global Acute Respiratory Distress Syndrome Treatment Market, growth prospects 2023-2030
  • FIG 6. Global Acute Respiratory Distress Syndrome Treatment Market, porters 5 force model
  • FIG 7. Global Acute Respiratory Distress Syndrome Treatment Market, pest analysis
  • FIG 8. Global Acute Respiratory Distress Syndrome Treatment Market, value chain analysis
  • FIG 9. Global Acute Respiratory Distress Syndrome Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Acute Respiratory Distress Syndrome Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Acute Respiratory Distress Syndrome Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Acute Respiratory Distress Syndrome Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Acute Respiratory Distress Syndrome Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Acute Respiratory Distress Syndrome Treatment Market, regional snapshot 2020 & 2030
  • FIG 15. North America Acute Respiratory Distress Syndrome Treatment Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Acute Respiratory Distress Syndrome Treatment Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia Pacific Acute Respiratory Distress Syndrome Treatment Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Acute Respiratory Distress Syndrome Treatment Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Acute Respiratory Distress Syndrome Treatment Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Acute Respiratory Distress Syndrome Treatment Market is valued at approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2023-2030. Acute Respiratory Distress Syndrome is a medical condition that can occur in response to various underlying causes, such as pneumonia, sepsis, trauma, or inhalation injury. ARDS is characterized by inflammation and fluid buildup in the lungs, which can lead to severe shortness of breath and respiratory failure. The Acute Respiratory Distress Syndrome Treatment market is expanding because of factors such as increasing cases of Preterm birth and growing prevalence of respiratory diseases. Treatment of ARDS typically involves supportive care, such as mechanical ventilation to help with breathing, supplemental oxygen, and medications to manage symptoms and prevent complications. Its prevalence has progressively increased during the last few decades.

According to the World Health Organization, every year, an estimated 15 million babies are born preterm. Furthermore, across countries, the rate of preterm birth ranges from 5% to 18% of babies born. Moreover, more than 90% of extremely preterm babies born in low-income countries die within the first few days of life, yet less than 10% of extremely preterm babies die in high-income settings. Another important component driving space is increased prevalence of respiratory diseases. According to World Health Organization, Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths. In addition, Chronic obstructive pulmonary disease is the third leading cause of death worldwide, causing 3.23 million deaths Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries in 2019. Also, increasing demand for diagnosis and rising technological advancement in medical testing devices would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Acute Respiratory Distress Syndrome Treatment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Acute Respiratory Distress Syndrome Treatment Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to technological advancements and the availability of numerous cutting-edge pharmacological molecules to improve the therapeutic process. According to Statista, the prevalence of chronic obstructive pulmonary disease in the United States is expected to increase to around 11.6% among adults by the year 2050. Asia Pacific is expected to grow significantly during the forecast period, owing to an increase in biotechnology research and center activity in the market space.

Major market players included in this report are:

  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • LivaNova PLC
  • Besmed Health Business Corp
  • Armstrong Medical
  • Pfizer Inc.

Recent Developments in the Market:

  • In April 2022, Novartis Pharma introduced Egypt's first fixed dose combination triple therapy in one device for asthma, with the purpose of enhancing patients' management as well as their quality of life.

Global Acute Respiratory Distress Syndrome Treatment Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Route of Administration, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class

  • Vasoconstrictors
  • Bronchodilators
  • Steroids and Antibiotics
  • Others

By Route of Administration

  • Oral
  • Injection
  • Inhalation

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Acute Respiratory Distress Syndrome Treatment Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Acute Respiratory Distress Syndrome Treatment Market, by Drug Class, 2020-2030 (USD Billion)
    • 1.2.3. Acute Respiratory Distress Syndrome Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.4. Acute Respiratory Distress Syndrome Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Acute Respiratory Distress Syndrome Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Acute Respiratory Distress Syndrome Treatment Market Dynamics

  • 3.1. Acute Respiratory Distress Syndrome Treatment Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing cases of Preterm birth
      • 3.1.1.2. Growing prevalence of respiratory diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Acute Respiratory Distress Syndrome Treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for diagnosis
      • 3.1.3.2. Rising technological advancement in medical testing devices

Chapter 4. Global Acute Respiratory Distress Syndrome Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Acute Respiratory Distress Syndrome Treatment Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Acute Respiratory Distress Syndrome Treatment Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Acute Respiratory Distress Syndrome Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
  • 5.4. Acute Respiratory Distress Syndrome Treatment Market, Sub Segment Analysis
    • 5.4.1. Vasoconstrictors
    • 5.4.2. Bronchodilators
    • 5.4.3. Steroids and Antibiotics
    • 5.4.4. Others

Chapter 6. Global Acute Respiratory Distress Syndrome Treatment Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Acute Respiratory Distress Syndrome Treatment Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Acute Respiratory Distress Syndrome Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 6.4. Acute Respiratory Distress Syndrome Treatment Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Injection
    • 6.4.3. Inhalation

Chapter 7. Global Acute Respiratory Distress Syndrome Treatment Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Acute Respiratory Distress Syndrome Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Acute Respiratory Distress Syndrome Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Acute Respiratory Distress Syndrome Treatment Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Pharmacies
    • 7.4.4. Others

Chapter 8. Global Acute Respiratory Distress Syndrome Treatment Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Acute Respiratory Distress Syndrome Treatment Market, Regional Market Snapshot
  • 8.4. North America Acute Respiratory Distress Syndrome Treatment Market
    • 8.4.1. U.S. Acute Respiratory Distress Syndrome Treatment Market
      • 8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Acute Respiratory Distress Syndrome Treatment Market
  • 8.5. Europe Acute Respiratory Distress Syndrome Treatment Market Snapshot
    • 8.5.1. U.K. Acute Respiratory Distress Syndrome Treatment Market
    • 8.5.2. Germany Acute Respiratory Distress Syndrome Treatment Market
    • 8.5.3. France Acute Respiratory Distress Syndrome Treatment Market
    • 8.5.4. Spain Acute Respiratory Distress Syndrome Treatment Market
    • 8.5.5. Italy Acute Respiratory Distress Syndrome Treatment Market
    • 8.5.6. Rest of Europe Acute Respiratory Distress Syndrome Treatment Market
  • 8.6. Asia-Pacific Acute Respiratory Distress Syndrome Treatment Market Snapshot
    • 8.6.1. China Acute Respiratory Distress Syndrome Treatment Market
    • 8.6.2. India Acute Respiratory Distress Syndrome Treatment Market
    • 8.6.3. Japan Acute Respiratory Distress Syndrome Treatment Market
    • 8.6.4. Australia Acute Respiratory Distress Syndrome Treatment Market
    • 8.6.5. South Korea Acute Respiratory Distress Syndrome Treatment Market
    • 8.6.6. Rest of Asia Pacific Acute Respiratory Distress Syndrome Treatment Market
  • 8.7. Latin America Acute Respiratory Distress Syndrome Treatment Market Snapshot
    • 8.7.1. Brazil Acute Respiratory Distress Syndrome Treatment Market
    • 8.7.2. Mexico Acute Respiratory Distress Syndrome Treatment Market
  • 8.8. Middle East & Africa Acute Respiratory Distress Syndrome Treatment Market
    • 8.8.1. Saudi Arabia Acute Respiratory Distress Syndrome Treatment Market
    • 8.8.2. South Africa Acute Respiratory Distress Syndrome Treatment Market
    • 8.8.3. Rest of Middle East & Africa Acute Respiratory Distress Syndrome Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Hoffmann-La Roche Ltd
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bayer AG
    • 9.3.3. Sun Pharmaceutical Industries Ltd
    • 9.3.4. Novartis AG
    • 9.3.5. Dragerwerk AG & Co. KGaA
    • 9.3.6. Fisher & Paykel Healthcare Limited
    • 9.3.7. LivaNova PLC
    • 9.3.8. Besmed Health Business Corp
    • 9.3.9. Armstrong Medical
    • 9.3.10. Pfizer Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption